Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. News
  7. Summary
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Delayed Nasdaq Copenhagen  -  10:59:49 2023-02-03 am EST
941.50 DKK   +3.91%
02/03European Equities Move Modestly Higher Friday, But Poised to End Week Lower
MT
02/03Trading in Novo Nordisk shares by board members, executives and associated persons
GL
02/03Technically solid
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Eurozone PMI Data Supports European Equities

11/23/2022 | 11:20am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -4.05% 1.66 Delayed Quote.18.49%
AMARIN CORPORATION PLC -3.08% 1.89 Delayed Quote.61.16%
ARCELORMITTAL 0.53% 28.61 Real-time Quote.16.42%
ASML HOLDING N.V. 0.71% 639.5 Real-time Quote.26.94%
BARCLAYS PLC 0.13% 188.64 Delayed Quote.19.00%
BRENT OIL -2.83% 79.73 Delayed Quote.-4.54%
CREDIT SUISSE GROUP AG -1.07% 3.316 Delayed Quote.19.97%
EQUINOR ASA 2.11% 299.85 Real-time Quote.-14.77%
ERICSSON -0.05% 62.57 Delayed Quote.2.74%
HSBC HOLDINGS PLC 0.96% 596.7 Delayed Quote.15.71%
LLOYDS BANKING GROUP PLC -0.30% 53.33 Delayed Quote.17.44%
NOVO NORDISK A/S 3.91% 941.5 Delayed Quote.0.37%
TOTALENERGIES SE 2.12% 56.35 Real-time Quote.-3.92%
WTI 0.00% 73.419 Delayed Quote.-5.67%
All news about NOVO NORDISK A/S
02/03European Equities Move Modestly Higher Friday, But Poised to End Week Lower
MT
02/03Trading in Novo Nordisk shares by board members, executives and associated persons
GL
02/02Trading in Novo Nordisk shares by board members, executives and associated persons
GL
02/02Trading in Novo Nordisk shares by board members, executives and associated persons
GL
02/02European Equities Move Lower Following ECB Rate Hike
MT
02/02NOVO NORDISK : Credit Suisse remains Neutral
MD
02/02NOVO NORDISK : Deutsche Bank gives a Buy rating
MD
02/01Health Care Up After GSK Earnings -- Health Care Roundup
DJ
02/01Global markets live: AMD, Amgen, Electronic Arts, PayPal, Snap...
MS
02/01Novo Nordisk Q4 Earnings, Sales Rise; Issues 2023 Outlook; to Start 28 Billion Kroner S..
MT
More news
Analyst Recommendations on NOVO NORDISK A/S
More recommendations
Financials
Sales 2023 200 B 29 101 M 29 101 M
Net income 2023 67 620 M 9 850 M 9 850 M
Net cash 2023 10 932 M 1 592 M 1 592 M
P/E ratio 2023 30,3x
Yield 2023 1,57%
Capitalization 2 125 B 310 B 310 B
EV / Sales 2023 10,6x
EV / Sales 2024 9,41x
Nbr of Employees 54 789
Free-Float 74,0%
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 941,50 DKK
Average target price 953,13 DKK
Spread / Average Target 1,24%
EPS Revisions
Managers and Directors
Lars Fruergaard J°rgensen President & Chief Executive Officer
Karsten Munk Knudsen Chief Financial Officer & Executive Vice President
Helge Lund Chairman
Henrik Ehlers Wulff Senior Vice President-Diabetes API
Stephen Gough Global Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
NOVO NORDISK A/S0.37%309 611
JOHNSON & JOHNSON-6.29%430 370
ELI LILLY AND COMPANY-9.61%322 186
ROCHE HOLDING AG-2.81%269 030
MERCK & CO., INC.-7.22%260 994
ABBVIE INC.-10.15%256 696